Liver Macrophages: Old Dogmas and New Insights

Inflammation is a hallmark of virtually all liver diseases, such as liver cancer, fibrosis, nonalcoholic steatohepatitis, alcoholic liver disease, and cholangiopathies. Liver macrophages have been thoroughly studied in human disease and mouse models, unravelling that the hepatic mononuclear phagocyt...

Full description

Bibliographic Details
Main Authors: Adrien Guillot, Frank Tacke
Format: Article
Language:English
Published: Wolters Kluwer Health/LWW 2019-06-01
Series:Hepatology Communications
Online Access:https://doi.org/10.1002/hep4.1356
_version_ 1828044923509669888
author Adrien Guillot
Frank Tacke
author_facet Adrien Guillot
Frank Tacke
author_sort Adrien Guillot
collection DOAJ
description Inflammation is a hallmark of virtually all liver diseases, such as liver cancer, fibrosis, nonalcoholic steatohepatitis, alcoholic liver disease, and cholangiopathies. Liver macrophages have been thoroughly studied in human disease and mouse models, unravelling that the hepatic mononuclear phagocyte system is more versatile and complex than previously believed. Liver macrophages mainly consist of liver‐resident phagocytes, or Kupffer cells (KCs), and bone marrow‐derived recruited monocytes. Although both cell populations in the liver demonstrate principal functions of macrophages, such as phagocytosis, danger signal recognition, cytokine release, antigen processing, and the ability to orchestrate immune responses, KCs and recruited monocytes retain characteristic ontogeny markers and remain remarkably distinct on several functional aspects. While KCs dominate the hepatic macrophage pool in homeostasis (“sentinel function”), monocyte‐derived macrophages prevail in acute or chronic injury (“emergency response team”), making them an interesting target for novel therapeutic approaches in liver disease. In addition, recent data acquired by unbiased large‐scale techniques, such as single‐cell RNA sequencing, unraveled a previously unrecognized complexity of human and murine macrophage polarization abilities, far beyond the old dogma of inflammatory (M1) and anti‐inflammatory (M2) macrophages. Despite tremendous progress, numerous challenges remain in deciphering the full spectrum of macrophage activation and its implication in either promoting liver disease progression or repairing injured liver tissue. Being aware of such heterogeneity in cell origin and function is of crucial importance when studying liver diseases, developing novel therapeutic interventions, defining macrophage‐based prognostic biomarkers, or designing clinical trials. Growing knowledge in gene expression modulation and emerging technologies in drug delivery may soon allow shaping macrophage populations toward orchestrating beneficial rather than detrimental inflammatory responses.
first_indexed 2024-04-10T18:02:46Z
format Article
id doaj.art-733d85af7e1f4c40a88bf4bbb24fd7f1
institution Directory Open Access Journal
issn 2471-254X
language English
last_indexed 2024-04-10T18:02:46Z
publishDate 2019-06-01
publisher Wolters Kluwer Health/LWW
record_format Article
series Hepatology Communications
spelling doaj.art-733d85af7e1f4c40a88bf4bbb24fd7f12023-02-02T14:43:12ZengWolters Kluwer Health/LWWHepatology Communications2471-254X2019-06-013673074310.1002/hep4.1356Liver Macrophages: Old Dogmas and New InsightsAdrien Guillot0Frank Tacke1Laboratory of Liver Diseases National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health Bethesda MDDepartment of Hepatology/Gastroenterology Charité University Medical Center Berlin GermanyInflammation is a hallmark of virtually all liver diseases, such as liver cancer, fibrosis, nonalcoholic steatohepatitis, alcoholic liver disease, and cholangiopathies. Liver macrophages have been thoroughly studied in human disease and mouse models, unravelling that the hepatic mononuclear phagocyte system is more versatile and complex than previously believed. Liver macrophages mainly consist of liver‐resident phagocytes, or Kupffer cells (KCs), and bone marrow‐derived recruited monocytes. Although both cell populations in the liver demonstrate principal functions of macrophages, such as phagocytosis, danger signal recognition, cytokine release, antigen processing, and the ability to orchestrate immune responses, KCs and recruited monocytes retain characteristic ontogeny markers and remain remarkably distinct on several functional aspects. While KCs dominate the hepatic macrophage pool in homeostasis (“sentinel function”), monocyte‐derived macrophages prevail in acute or chronic injury (“emergency response team”), making them an interesting target for novel therapeutic approaches in liver disease. In addition, recent data acquired by unbiased large‐scale techniques, such as single‐cell RNA sequencing, unraveled a previously unrecognized complexity of human and murine macrophage polarization abilities, far beyond the old dogma of inflammatory (M1) and anti‐inflammatory (M2) macrophages. Despite tremendous progress, numerous challenges remain in deciphering the full spectrum of macrophage activation and its implication in either promoting liver disease progression or repairing injured liver tissue. Being aware of such heterogeneity in cell origin and function is of crucial importance when studying liver diseases, developing novel therapeutic interventions, defining macrophage‐based prognostic biomarkers, or designing clinical trials. Growing knowledge in gene expression modulation and emerging technologies in drug delivery may soon allow shaping macrophage populations toward orchestrating beneficial rather than detrimental inflammatory responses.https://doi.org/10.1002/hep4.1356
spellingShingle Adrien Guillot
Frank Tacke
Liver Macrophages: Old Dogmas and New Insights
Hepatology Communications
title Liver Macrophages: Old Dogmas and New Insights
title_full Liver Macrophages: Old Dogmas and New Insights
title_fullStr Liver Macrophages: Old Dogmas and New Insights
title_full_unstemmed Liver Macrophages: Old Dogmas and New Insights
title_short Liver Macrophages: Old Dogmas and New Insights
title_sort liver macrophages old dogmas and new insights
url https://doi.org/10.1002/hep4.1356
work_keys_str_mv AT adrienguillot livermacrophagesolddogmasandnewinsights
AT franktacke livermacrophagesolddogmasandnewinsights